Therapy/Cord Blood

Stem Cells Show Promise for Both Transplantation and Gene Therapy

Published in Cancer Weekly, July 24th, 1995

Despite numerous obstacles, the application of cord blood may turn out to be larger for gene therapy than for strict transplants or treatment of malignant disease.

The exciting prospect of correcting genetic defects or introducing whole new properties to the bone marrow through the use of umbilical cord blood shows promise, but large obstacles remain before some of the most exciting therapies can be practiced, indicated medical writer Clare Thompson ("Umbilical Cords: Turning Garbage into Clinical Gold," Science, May 12, 1995;268:805-806).

Thompson reported that Donald Kohn, Children's Hospital of the University of Southern California in Los Angeles...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-07-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry